NHS in the East Midlands Partners with McKesson

McKessonMcKesson UK, the trusted healthcare technology solutions and services provider, announced that East Midlands' commissioning services organisation EMPACT (East Midlands Procurement and Commissioning Transformation) has selected InterQual to provide evidence-based guidelines assessment across the region's PCTs, acute trusts and community hospitals. EMPACT has commenced a rapid roll-out of InterQual as part of regional utilisation review programme across the East Midlands with a series of snapshot utilisation reviews, which will assist local healthcare organisations in identifying bottlenecks in the system. These findings will enable PCTs to align and redesign services where appropriate to ensure patients receive the right care, in the right place and at the right time.

With the NHS undergoing significant reform and healthcare organisations required to deliver significant efficiency savings, EMPACT is supporting local healthcare economies across the region in utilising technology to identify where InterQual could be used to deliver efficiency savings and identify a clinical evidence base for transforming services whilst ensuring best practice and high-quality patient-centred care across the region.

EMPACT's utilisation review team are working with McKesson to support implementation of snapshot utilisation reviews with progression to permanent point of care use of InterQual by front line staff on a daily basis. Peter Huskinson, Director of Commissioning Services at EMPACT, comments, "We selected McKesson due to their knowledge and experience of delivering high quality solutions to the NHS, as well as the track record of InterQual not only internationally but specifically within the UK. InterQual can be transferred and utilised across the whole care spectrum providing powerful information to the commissioners of today and for the GP commissioners of the future. EMPACT is able to support the changing landscape of the NHS and will continue to deliver intelligent and evidence-based changes in partnership with McKesson, enabling consistency in high quality care and reorganising services centred around the patient."

Huskinson continues, "Through the use of EMPACT's services in collaboration with McKesson's robust InterQual evidence-based care tool, we aim to have a continuous flow of patient-level data to support clinical decision-making and ensure each care setting is appropriate to the individual patient. We are currently working with PCTs and acute trusts across the region initially focusing on emergency admissions at Nottinghamshire and Lincoln, ambulatory care in Chesterfield and intermediate care at Derby. By implementing InterQual we aim to reduce inappropriate hospital admissions, minimise clinical variance and any inconsistencies in practice across the region, as well as support transformation and service redesign where required."

Barbara Brady, Consultant in Public Health, who played a significant role in the evaluation of the solution and service delivered collaboratively by McKesson and EMPACT, adds, "Currently we don't have sufficient data to understand, for example, how many acute admissions didn't meet inpatient criteria. Access to this level of information through InterQual will help inform clinicians on the most appropriate care setting for the patient in question whether that’s emergency care, acute care, intermediate care or treatment at home."

Matthew Hunt, Director of Care Management at McKesson, comments "We are delighted that EMPACT have selected InterQual to provide evidence-based guidelines assessment across the East Midlands region. The power of InterQual lies in its rich repository of World Class Clinical content. InterQual has been refined and proven over 30 years and benefits from a rigorous development cycle that is underpinned by a systematic, critical assessment of the latest in medical evidence (37% of which is derived outside of the USA) and validated by an independent panel of 800 clinical experts. As a result, InterQual criteria have a level of credibility and integrity that cannot be found anywhere else. Partnering with EMPACT allows us to deploy the technology at scale and pace, with shared learning from and support to each local implementation."

Gill Collinson, Director of Engagement and Executive Nurse at NHS Derby City, comments, "Clinicians are engaged at an early stage in each local implementation and the interest and commitment from clinical staff member is essential as we continue to move the project forward. EMPACT has been running a series of clinical engagement sessions which have been a resounding success and the healthcare organisations across the region are eager to roll-out the solution and undergo assessment. The interest and commitment from clinical staff is essential as we continue to move the project forward."

David Sharp, Chief Executive at NHS Derbyshire County, concludes, "The snapshot utilisation review process will also help each Trust deepen their understanding of the local healthcare system and set achievable goals for change. EMPACT will be working closely with the commissioners, managers, clinicians and with McKesson to help define and deliver their objectives. The utilisation review and evidence-based care tool will assist organisations in the transformation of patient care services throughout the East Midlands, delivering best practice and appropriate care to the 4.3m local population."

About EMPACT
EMPACT was established in 2010 to support commissioners across the East Midlands health economies, working with a wide range of partners as a joint venture funded by the region's PCTs with support from NHS East Midlands. EMPACT's role is to deliver Specialist Support to local commissioners including in Business Intelligence, Healthcare Market Development, Procurement Support, and Contract and System Management.

EMPACT's remit is "Collaborative Impact for Improving Health". It supports the adoption and specification of best practice and enables commissioners to access best practice to achieve spread and consistency with appropriate localisation. It applies business intelligence tools and comparative analytics for commissioners, deploy Innovative commissioning technologies and act as a clear front door for commercial innovators as well as delivering collaborative projects to reform specific sectors of healthcare in response to local needs and priorities.

About McKesson UK
McKesson, the trusted healthcare technology solutions and services provider, has operated in the UK since 1991 and has a dedicated 500 strong workforce delivering to virtually every NHS organisation as well as to a number of other public and private sector organisations. As operators of the world's largest integrated HR and Payroll system - the Electronic Staff Record (ESR) - McKesson pays 7% of the working population in England and Wales, a workforce of more than 1.4 million NHS employees.

McKesson UK is a subsidiary of McKesson Corporation, which currently ranks 14th on the FORTUNE 500. McKesson is the longest-operating company in healthcare today, with over 175 years experience. Globally, McKesson employs more than 32,000 staff providing information technology, pharmaceuticals, pharmacy automation and disease management solutions to support healthcare delivery in a number of countries. Throughout the world, McKesson is a company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care.

www.mckesson.co.uk

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...